Danaher forecasts 2027 core growth of 4%-5% ex respiratory while lifting 2026 adjusted EPS guidance to $8.57-$8.62

Danaher (DHR) Q3 2026 earnings call: CEO reset, AI/autonomous lab push, margins/FCF jump, EPS raise and 2027 outlook.